Last reviewed · How we verify

Prasterone (DHEA) — Competitive Intelligence Brief

Prasterone (DHEA) (Prasterone (DHEA)) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Steroid hormone precursor. Area: Women's Health / Gynecology.

phase 3 Steroid hormone precursor Estrogen receptor (ER), Androgen receptor (AR) Women's Health / Gynecology Small molecule Live · refreshed every 30 min

Target snapshot

Prasterone (DHEA) (Prasterone (DHEA)) — EndoCeutics Inc.. Prasterone (DHEA) is a steroid hormone precursor that acts as a substrate for the synthesis of estrogen and androgen, restoring hormonal balance in postmenopausal women.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Prasterone (DHEA) TARGET Prasterone (DHEA) EndoCeutics Inc. phase 3 Steroid hormone precursor Estrogen receptor (ER), Androgen receptor (AR)
Prasterone (DHEA), Micronized Prasterone (DHEA), Micronized Hospital Clinic of Barcelona marketed Steroid hormone precursor Androgen receptor, estrogen receptor (indirect via metabolic conversion)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Steroid hormone precursor class)

  1. EndoCeutics Inc. · 1 drug in this class
  2. Hospital Clinic of Barcelona · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Prasterone (DHEA) — Competitive Intelligence Brief. https://druglandscape.com/ci/prasterone-dhea. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: